Endemic hepatitis B virus infection and chronic liver disease mortality in the Republic of Palau, 1990-2002

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 100, Issue 12, 2006, Pages 1130-1134

  Vogt, Tara M ^a   Goldstein, Susan T ^a   Kuartei, Stevenson ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b Palau Ministry of Health   (Palau)

Author keywords

Hepatitis; Hepatitis B virus; Hepatocellular carcinoma; Liver cirrhosis; Pacific Islands; Republic of Palau; Vaccination

Indexed keywords

ADULT; AGED; ARTICLE; CAUSE OF DEATH; CHRONIC LIVER DISEASE; DATA BASE; DEATH CERTIFICATE; ENDEMIC DISEASE; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; PALAU; RISK FACTOR; SEROLOGY; STATISTICAL ANALYSIS;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CHRONIC DISEASE; ENDEMIC DISEASES; FEMALE; HEPATITIS B, CHRONIC; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PACIFIC ISLANDS; SEX DISTRIBUTION; SURVIVAL RATE;

HEPATITIS B VIRUS;

EID: 33749058082     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trstmh.2006.01.011     Document Type: Article

References (28)

1. Beasley R.P. Hepatitis B virus. The major etiology of hepatocellular carcinoma. Cancer 61 (1988) 1942-1956
2. Bosch F.X., Ribes J., Cleries R., and Diaz M. Epidemiology of hepatocellular carcinoma. Clin. Liver Dis. 9 (2005) 191-211
3. Bureau of Budget and Planning. Palau Statistical Yearbook (2002), Ministry of Administration, Koror, Palau
4. CDC. Global progress toward universal childhood hepatitis B vaccination, 2003. MMWR Morb. Mortal. Wkly Rep. 52 (2003) 868-870
5. Chen C.J., Wang L.Y., and Yu M.W. Epidemiology of hepatitis B virus infection in the Asia-Pacific region. J. Gastroenterol. Hepatol. 15 Suppl. (2000) E3-E6
6. Donato F., Tagger A., Gelatti U., Parrinello G., Boffetta P., Albertini A., Decarli A., Trevisi P., Ribero M.L., Martelli C., Porru S., and Nardi G. Alcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and women. Am. J. Epidemiol. 155 (2002) 323-331
7. Goldstein S.T., Zhou F., Hadler S.C., Bell B.P., Mast E.E., and Margolis H.S. A mathematical model to estimate global hepatitis B disease burden and vaccination impact. Int. J. Epidemiol. 34 (2005) 1329-1339
8. Hsieh C.C., Tzonou A., Zavitsanos X., Kaklamani E., Lan S.J., and Trichopoulos D. Age at first establishment of chronic hepatitis B virus infection and hepatocellular carcinoma risk. A birth order study. Am. J. Epidemiol. 136 (1992) 1115-1121
9. Hurwitz E.S., Holman R.C., Strine T.W., and Chorba T.L. Chronic liver disease mortality in the United States, 1979 through 1989. Am. J. Public Health 85 (1995) 1256-1260
10. Hyams K.C. Risks of chronicity following acute hepatitis B virus infection: a review. Clin. Infect. Dis. 20 (1995) 992-1000
11. Kelsey J.L., Whittemore A.S., Evans A.S., and Thompson W.D. Methods in Observational Epidemiology Vol. 2 (1996), Oxford University Press, New York
12. Kuartei, S., Erb-Alvarez, J., 2003. Report: Palau Community Health Assessment. Palau Ministry of Health, Koror, Palau.
13. Lin H.H., Wang L.Y., Hu C.T., Huang S.C., Huang L.C., Lin S.S., Chiang Y.M., Liu T.T., and Chen C.L. Decline of hepatitis B carrier rate in vaccinated and unvaccinated subjects: sixteen years after newborn vaccination program in Taiwan. J. Med. Virol. 69 (2003) 471-474
14. Llovet J.M., Burroughs A., and Bruix J. Hepatocellular carcinoma. Lancet 362 (2003) 1907-1917
15. Mahoney F.J. Update on diagnosis, management, and prevention of hepatitis B virus infection. Clin. Microbiol. Rev. 12 (1999) 351-366
16. Mahoney F.J., Woodruff B.A., Auerbach S., Polloi A., McCready J., Durand M., Aniol K., Reed E., Williams I., and Pretrick E. Progress on the elimination of hepatitis B virus transmission in Micronesia and American Samoa. Pac. Heath Dialog 3 (2005) 140-146
17. Mandayam S., Jamal M.M., and Morgan T.R. Epidemiology of alcoholic liver disease. Semin. Liver Dis. 24 (2004) 217-232
18. Margolis H.S., Coleman P.J., Brown R.E., Mast E.E., Sheingold S.H., and Arevalo J.A. Prevention of hepatitis B virus transmission by immunization. An economic analysis of current recommendations. JAMA 274 (1995) 1201-1208
19. Morens, D.M., Polloi, A.H., Silberman, C., Williams, R.P., Katz, A.R., Grove, J.S.; The Palau Prevention Study Team, 1997. Report: The 1991 Palau Prevention Study: investigation of HIV-related risk behaviors in an HIV-free United States-affiliated Micronesian population. Palau Ministry of Health, Koror.
20. Perz, J.F., Farrington, L.A., Armstrong, G.L., Hutin, Y.J.F., Bell, B.P., 2004. Hepatocellular carcinoma and cirrhosis: global estimates of fractions attributable to viral infection, in: National Institutes of Health Conference: Hepatocellular Carcinoma: Screening, Diagnosis and Management. National Institutes of Health, Bethesda, MD.
21. Shepard C.W., Finelli L., and Alter M.J. Global epidemiology of hepatitis C virus infection. Lancet Infect. Dis. 5 (2005) 558-567
22. Tsai J.F., Chang W.Y., Jeng J.E., Ho M.S., Wang L.Y., Hsieh M.Y., Chen S.C., Chuang W.L., Lin Z.Y., and Tsai J.H. Hepatitis C virus infection as a risk factor for non-alcoholic liver cirrhosis in Taiwan. J. Med. Virol. 41 (1993) 296-300
23. Tsai J.F., Jeng J.E., Ho M.S., Chang W.Y., Hsieh M.Y., Lin Z.Y., and Tsai J.H. Additive effect modification of hepatitis B surface antigen and e antigen on the development of hepatocellular carcinoma. Br. J. Cancer 73 (1996) 1498-1502
24. Williams I.T., Goldstein S.T., Tufa J., Tauillii S., Margolis H.S., and Mahoney F.J. Long term antibody response to hepatitis B vaccination beginning at birth and to subsequent booster vaccination. Pediatr. Infect. Dis. J. 22 (2003) 157-163
25. WHO. The World Health Report: 2003: Shaping the Future (2003), World Health Organization, Geneva, Switzerland
26. WHO Statistical Information System, 2006. Global burden of disease estimates.http://www3.who.int/whosis/menu.cfm?path=whosis,bod,burden,burden_estimates&language=english. [accessed 17 January 2006].
27. Wilson N., Ruff T.A., Rana B.J., Leydon J., and Locarnini S. The effectiveness of the infant hepatitis B immunisation program in Fiji, Kiribati, Tonga and Vanuatu. Vaccine 18 (2000) 3059-3066
28. World Health Assembly, 1992. Immunization and vaccine quality. Resolution WHA 45.17. World Health Assembly, Geneva.